BIOXCEL THERAPEUTICS INC (BTAI) Stock Income Statement
NASDAQ:BTAI - Nasdaq - US09075P2048 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.85M | 2.27M | 1.38M | 380.00K | 0.00 | |||
| Cost Of Goods | 2.08M | 2.14M | 1.26M | 20.00K | N/A | |||
| Gross Profit | -226.00K | 123.00K | 120.00K | 360.00K | N/A | |||
| Operating Expenses | 50.51M | 64.93M | 167.74M | 160.00M | 106.94M | |||
| Research and Development | 23.59M | 30.43M | 84.33M | 91.24M | 52.71M | |||
| Selling, General, and Administrative Expenses | 26.93M | 34.49M | 83.41M | 68.76M | 54.23M | |||
| Operating Income | -50.74M | -64.80M | -167.62M | -159.65M | -106.94M | |||
| Interest Income/Expense | -13.58M | -12.53M | -7.67M | -5.69M | 0.00 | |||
| Other Income/Expense | 26.70M | 20.17M | 394.00K | -430.00K | N/A | |||
| Non Recurring Items | N/A | -2.44M | -4.16M | N/A | N/A | |||
| Income Before Taxes | -40.06M | -59.60M | -179.05M | -165.76M | -106.93M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -40.06M | -59.60M | -179.05M | -165.76M | -106.93M | |||
| EBITDA | -50.43M | -64.50M | -167.30M | -159.32M | -106.64M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -14.24 | -23.51 | -98.35 | -94.66 | -64.87 | |||
| Non GAAP EPS | -13.55 | -25.97 | -98.40 | -94.59 | -65.28 | |||
| Statistics | ||||||||
| Gross Profit Margin | -12.20% | 5.43% | 8.70% | 94.74% | N/A | |||
| Profit Margin | -2163.17% | -2630.14% | -12974.86% | -43621.05% | N/A | |||
| Operating Profit Margin | -2739.74% | -2859.84% | -12146.30% | -42013.16% | N/A | |||
All data in USD